Jell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 07-12-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 47.50 Cr
as on 07-12-2024
- Revenue 29.55%
(FY 2022)
- Profit -14.07%
(FY 2022)
- Ebitda -13.66%
(FY 2022)
- Net Worth 25.12%
(FY 2022)
- Total Assets 20.03%
(FY 2022)
About Jell Pharmaceuticals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹47.50 Cr.
Chirag Mehta and Sanjay Mehta serve as directors at the Company.
- CIN/LLPIN
U23200MH1994PTC080671
- Company No.
080671
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jell Pharmaceuticals Private Limited offer?
Jell Pharmaceuticals Private Limited offers a wide range of products and services, including Child and Baby Care Products, Baby Care Products, Cosmetics, Hair & Beauty Products, Skin Creams, Hair Care Cosmetics, Artificial & Decorative Candles, Candle, Body Care Products, Body Lotions, Moisturizing Lotion.
Who are the key members and board of directors at Jell Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Mehta  | Whole-Time Director | 31-Aug-1994 | Current |
| Chirag Mehta | Whole-Time Director | 31-Aug-1994 | Current |
Financial Performance of Jell Pharmaceuticals.
Jell Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.55% increase. The company also saw a substantial fall in profitability, with a 14.07% decrease in profit. The company's net worth Soared by an impressive increase of 25.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jell Pharmaceuticals?
In 2022, Jell Pharmaceuticals had a promoter holding of 31.35% and a public holding of 68.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunil Paint And Varnishers Company Private LimitedActive 34 years 4 monthsChirag Mehta and Sanjay Mehta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Jul 2024 | ₹1.00 Cr | Open |
Bank Of India Creation Date: 14 Dec 2011 | ₹3.00 Cr | Open |
Bank Of India Creation Date: 25 Jan 2007 | ₹43.50 Cr | Open |
How Many Employees Work at Jell Pharmaceuticals?
Jell Pharmaceuticals has a workforce of 186 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
